ALFA Finder| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 41.6 | 25.3 | 33.9 |
| Other income | 0.6 | 0.3 | 0.1 |
| Total income | 42.3 | 25.6 | 34.0 |
| Profit before exceptional items & tax | 10.2 | -1.0 | 7.5 |
| Profit before tax | 10.2 | -1.0 | 7.5 |
| Net profit | 7.4 | -0.8 | 5.6 |
| Operating margin | 24.1% | -3.9% | 22.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +32.10% |
|---|---|
| Revenue, year on year | +22.70% |
NSE results filing, NSE: AAKAAR. Figures extracted from the filing.
Aakaar Medical Technologies Ltd: key numbers
- Share price
- ₹72.00
- Market cap
- ₹102.0 Cr
- Revenue (annual)
- ₹66.96 Cr
- Net profit (annual)
- ₹6.64 Cr
- P/E (TTM)
- 15.4×Sector 54.5×
- Promoter holding
- 67.05%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aakaar Medical Technologies Ltd
All →Aakaar Medical Technologies Annual General Meeting
Aakaar Medical Technologies issued a Postal Ballot Notice seeking approval to appoint Mr. Abhash Meswani as Whole-Time Director with ₹50 lakh annual remuneration for five years.
Aakaar Medical Technologies Earnings Call Transcript: Key Takeaways
H1 FY27 revenue of ₹43.72 Cr (+72.64% YoY) and PAT of ₹3.54 Cr versus a prior loss. Margins were deliberately sacrificed for marketing and the distributor transition. Debtor days (219) and cash (₹1.05 Cr) are the key weak spots.
- Call
- Guides 36% growth
Aakaar Medical Technologies H1 FY27 Results: Turns Profitable, Net Profit ₹3.5 Cr
Aakaar Medical Technologies Ltd reported revenue from operations of ₹43.7 Cr (+72.7% YoY) and net profit of ₹3.5 Cr for H1 FY27.
- Key figure
- Net profit ₹3.5 Cr
Aakaar Medical Technologies Investor Presentation: Key Takeaways
H1 FY27 revenue ₹43.72 Cr (+72.6% YoY), EBITDA ₹5.43 Cr (12.42%), PAT ₹3.54 Cr vs prior loss ₹0.78 Cr. Strategy: doctor-led B2B2C distribution, Xelix clinic network, debtor-days reduction.
Aakaar Medical Technologies Board Meeting Date
Aakaar Medical Technologies Limited will hold a board meeting on 30-Oct-2026 to consider unaudited half-yearly financial results and ESOP matters.
Aakaar Medical Technologies Other Announcement
Aakaar Medical Technologies Limited submitted its Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026. The report confirms total issued capital remains at 1,41,72,816 equity shares.